|
Volumn 109, Issue 1, 2002, Pages 91-99
|
Noradrenergic antidepressants: Does chronic treatment increase or decrease nuclear CREB-P?
|
Author keywords
Desipramine (DMI); Human fibroblasts; Nuclear CREB P; Rat frontal cortex; Reboxetine; Venlafaxine
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BETA ADRENERGIC RECEPTOR;
CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;
DESIPRAMINE;
NORADRENALIN;
REBOXETINE;
VENLAFAXINE;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DEPRESSION;
DRUG EFFECT;
FIBROBLAST;
FRONTAL CORTEX;
HUMAN;
HUMAN CELL;
MALE;
NONHUMAN;
NORADRENERGIC SYSTEM;
PRIORITY JOURNAL;
RECEPTOR DOWN REGULATION;
REDUCTION;
SECOND MESSENGER;
ANIMALS;
ANTIDEPRESSIVE AGENTS;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
CELL NUCLEUS;
CELLS, CULTURED;
CEREBRAL CORTEX;
CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN;
CYCLOHEXANOLS;
DESIPRAMINE;
FIBROBLASTS;
HUMANS;
MALE;
MORPHOLINES;
RATS;
RATS, SPRAGUE-DAWLEY;
TIME FACTORS;
|
EID: 0036169831
PISSN: 03009564
EISSN: None
Source Type: Journal
DOI: 10.1007/s702-002-8239-6 Document Type: Article |
Times cited : (38)
|
References (33)
|